Amphix Bio, Inc
Amphix Bio, Inc. is a Chicago-based biotechnology company focused on developing innovative regenerative therapeutics aimed at promoting healing following traumatic injuries and enhancing human healthspan. Utilizing a transformative therapeutic platform based on supramolecular chemistry, the company aims to restore functionality in neurological and musculoskeletal disorders through effective, cell-free treatments.
Founded on over two decades of research by Prof. Samuel Stupp at Northwestern University, Amphix Bio's platform has been validated by numerous peer-reviewed publications and patents. The company is advancing a diverse pipeline of candidates, including therapies for acute spinal cord injury, ischemic stroke, and degenerative disc disease, among others.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

